The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells
Sweta B. Patel, Daniel R Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra A. Crook, Maxwell C. McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, Tracy N. Young, Anna E. Krug, Connon I. Thomas, Caitlin Price, Monica Ransom, , Eric Martin Pietras
This study identifies NAMPT as a metabolic vulnerability in HR-MDS HSPCs, showing its inhibition reduces their survival and disease burden.
Blood Cancer Discovery · Jul 17, 2026Peer-reviewedCancer Biology